Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. MDS/AML patients benefit from novel study

    ... shows patients ineligible for studies may benefit from trial participation Article ... who potentially could benefit most from participation in clinical trials due to poor prognoses often are not included based on ...

    Article last updated 12/08/2016 - 2:34pm.

  2. Drug reduces acute GVHD in unrelated HSCTs

    ... at data for relapse because vorinostat is used in many clinical trials now as an anti-cancer drug. The relapse rate in our short-term ... intensity conditioning HSCT.2 In the phase II trial, 37 patients ≥18 years with a hematologic malignancy for which ...

    Article last updated 02/27/2017 - 1:45pm.

  3. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... the study: a.         Previous participation in a clinical study of IV or oral rigosertib; however, patients who failed screening ...

    Clinical Trial last updated 05/04/2018 - 3:53pm.

  4. Battling Aplastic Anemia, Seeking Information

    ... 6-month ATG (horse) therapy combined with Eltrombopag  clinical trial , a perfect 10-of-10 match was found and I had a successful  bone ...

    Patient Chronicle last updated 04/26/2018 - 10:30am.

  5. Taming the nausea, vomiting caused by chemo

    ... , according to results from a large NCI-funded phase III clinical trial . Patients in the trial were being treated with chemotherapy ...

    Article last updated 08/11/2016 - 3:27pm.

  6. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    ... Background The molecular determinants of clinical responses to decitabine therapy in patients with acute myeloid ... 84 adult patients with AML or MDS in a single-institution trial of decitabine to identify somatic mutations and their relationships to ...

    Research Article last updated 01/26/2017 - 10:07am.

  7. Medical “Must-See” TV in May

    ... and followed first in human patients throughout their entire trial. This unique access is the product of Hoffman’s nearly twenty years of ... an elemental level and at our most profound.” "The NIH Clinical Center’s more than 60-year history has resulted in remarkable ...

    Article last updated 02/02/2017 - 9:48am.

  8. A Rare Case of Aplastic Anemia Later in Life Won't Stop Me

    ... had no response to.  So in late 2013, they put me in a clinical trial for eltrombopag, which I had already tried once before, but this is ...

    Patient Chronicle last updated 04/26/2018 - 10:42am.

  9. Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia

    ... with the drug for years. In our aplastic anemia trial several patients have been on the drug for over two years. Is ... MDS. Do you have a timeline for the Phase 3 clinical trial period and how soon Eltrombopag could be possibly be ...

    Interview last updated 07/06/2012 - 3:42pm.

  10. A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination with Azacitidine for the Treatment of TP53 Mutant Myeloid Neoplasms

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... the efficacy, appropriateness or suitability of any clinical trial listed on this website. Pharmaceutical company sponsored ...

    Clinical Trial last updated 04/21/2018 - 6:04pm.